All Stories

  1. Polytherapy and Multimorbidity Pattern of Users of Anti-VEGF Drugs and Dexamethasone for the Treatment of Age-Related Macular Degeneration and other Vascular Retinopathies in Clinical Practice

    Article • Pharmaceuticals, April 2023, MDPI AG

    PhD Antonio Addis

  2. Nirsevimab come immunoprofilassi universale dell’infezione da virus respiratorio sinciziale?

    Article • Medico e Bambino, March 2023, Medico e Bambino

    PhD Antonio Addis

  3. Palivizumab reimbursement criteria and neonatal RSV hospitalisation: a regional retrospective review

    Article • BMJ Paediatrics Open, February 2021, BMJ

    PhD Antonio Addis

  4. Real world data to identify target population for new CAR‐T therapies

    Article • Pharmacoepidemiology and Drug Safety, November 2020, Wiley

    PhD Antonio Addis

  5. Lasciate ogni speranza voi che non sperimentate: il Recovery collaborative group e il Recovery fund

    Article • Medico e Bambino, November 2020, Medico e Bambino

    PhD Antonio Addis

  6. Promoting Better Clinical Trials and Drug Information as Public Health Interventions for the COVID-19 Emergency in Italy

    Article • Annals of Internal Medicine, October 2020, American College of Physicians

    PhD Antonio Addis

  7. Drug discontinuation in pregnant women with psoriasis: The PSO ‐ MOTHER cohort study

    Article • Pharmacoepidemiology and Drug Safety, June 2020, Wiley

    PhD Antonio Addis

  8. How Do Drug Regulatory Bodies Deal With Potential Innovative Therapies?

    Article • Therapeutic Innovation & Regulatory Science, January 2020, Springer Science + Business Media

    PhD Antonio Addis

  9. Anticancer drug prices and clinical outcomes: a cross-sectional study in Italy

    Article • BMJ Open, December 2019, BMJ

    PhD Antonio Addis

  10. Using GRADE methodology to assess innovation of new medicinal products in Italy

    Article • British Journal of Clinical Pharmacology, November 2019, Wiley

    PhD Antonio Addis

  11. Healthcare Database Networks for Drug Regulatory Policies: International Workshop on the Canadian, US and Spanish Experience and Future Steps for Italy

    Article • Drug Safety, October 2019, Springer Science + Business Media

    PhD Antonio Addis

  12. In Search of Predictors of Switching Between Erythropoiesis-Stimulating Agents in Clinical Practice: A Multi-Regional Cohort Study

    Article • BioDrugs, October 2019, Springer Science + Business Media

    PhD Antonio Addis

  13. Effectiveness and Safety of Switching Originator and Biosimilar Epoetins in Patients with Chronic Kidney Disease in a Large-Scale Italian Cohort Study

    Article • Drug Safety, June 2019, Springer Science + Business Media

    PhD Antonio Addis

  14. Role of healthcare databases and registries for surveillance of orphan drugs in the real-world setting: the Italian case study

    Article • Expert Opinion on Drug Safety, May 2019, Taylor & Francis

    PhD Antonio Addis, Dr Lorenzo Cavagna

  15. How Do Drug Regulatory Bodies Deal With Potential Innovative Therapies?

    Article • Therapeutic Innovation & Regulatory Science, January 2019, SAGE Publications

    Federico Villa, PhD Antonio Addis

  16. Workshop on the Italian Pharmacovigilance System in the International Context: Critical Issues and Perspectives

    Article • Drug Safety, December 2018, Springer Science + Business Media

    PhD Antonio Addis

  17. Neonatal outcomes following new reimbursement limitations on palivizumab in Italy

    Article • Archives of Disease in Childhood, September 2018, BMJ

    PhD Antonio Addis

  18. Studies on drug switchability showed heterogeneity in methodological approaches: a scoping review

    Article • Journal of Clinical Epidemiology, September 2018, Elsevier

    PhD Antonio Addis

  19. Pattern of Use of Biosimilar and Originator Somatropin in Italy: A Population-Based Multiple Databases Study During the Years 2009–2014

    Article • Frontiers in Endocrinology, March 2018, Frontiers

    PhD Antonio Addis

  20. Population-based cohort study on comparative effectiveness and safety of biologics in inflammatory bowel disease

    Article • Clinical Epidemiology, February 2018, Dove Medical Press

    Riccardo Di Domenicantonio, PhD Antonio Addis

  21. Biologics combined with conventional systemic agents or phototherapy for the treatment of psoriasis: real-life data from PSONET registries

    Article • Journal of the European Academy of Dermatology and Venereology, October 2017, Wiley

    PhD Antonio Addis, Phyllis Spuls

  22. Folic Acid for the Prevention of Neural Tube Defects

    Article • JAMA Pediatrics, July 2017, American Medical Association (AMA)

    PhD Antonio Addis

  23. Comparative efficacy and safety in ESA biosimilars vs. originators in adults with chronic kidney disease: a systematic review and meta-analysis

    Article • Journal of Nephrology, June 2017, Springer Science + Business Media

    PhD Antonio Addis

  24. Inequalities in access to biological treatments for psoriasis: results from the Italian Psocare registry

    Article • British Journal of Dermatology, April 2017, Wiley

    PhD Antonio Addis

  25. Impact of Guidance on the Prescription Patterns of G-CSFs for the Prevention of Febrile Neutropenia Following Anticancer Chemotherapy: A Population-Based Utilization Study in the Lazio Region

    Article • BioDrugs, March 2017, Springer Science + Business Media

    PhD Antonio Addis

  26. Comparative effectiveness and safety of erythropoiesis-stimulating agents (biosimilars vs originators) in clinical practice: a population-based cohort study in Italy

    Article • BMJ Open, March 2017, BMJ

    PhD Antonio Addis

  27. Can systematic reviews contribute to regulatory decisions?

    Article • European Journal of Clinical Pharmacology, January 2017, Springer Science + Business Media

    PhD Antonio Addis

  28. Risk of serious infections, cutaneous bacterial infections, and granulomatous infections in patients with psoriasis treated with anti–tumor necrosis factor agents versus classic therapies: Prospective meta-analysis of Psonet registries

    Article • Journal of the American Academy of Dermatology, September 2016, Elsevier

    Dr Ignacio Garcia-Doval, PhD Antonio Addis

  29. AIRWAYS-ICPs (European Innovation Partnership on Active and Healthy Ageing) from concept to implementation

    Article • European Respiratory Journal, April 2016, European Respiratory Society (ERS)

    PhD Antonio Addis, josep roca, Professor Adnan Custovic

  30. Integrated care pathways for airway diseases (AIRWAYS-ICPs)

    Article • European Respiratory Journal, June 2014, European Respiratory Society (ERS)

    Professor Anh Tuan Dinh-Xuan, PhD Antonio Addis, josep roca, Professor Adnan Custovic

  31. International collaboration to assess the risk of Guillain Barré Syndrome following Influenza A (H1N1) 2009 monovalent vaccines

    Article • Vaccine, September 2013, Elsevier

    PhD Antonio Addis, Dr Pedro Jesus Serrano-Castro

  32. Drotrecogin alfa (activated) in severe sepsis

    Article • The Lancet Infectious Diseases, February 2013, Elsevier

    PhD Antonio Addis

  33. The pharmacovigilance program on natalizumab in Italy: 2 years of experience

    Article • Neurological Sciences, October 2009, Springer Science + Business Media

    PhD Antonio Addis

  34. The Italian Horizon Scanning Project

    Article • European Journal of Clinical Pharmacology, June 2009, Springer Science + Business Media

    PhD Antonio Addis

  35. Natalizumab: a country-based surveillance program

    Article • Neurological Sciences, August 2008, Springer Science + Business Media

    PhD Antonio Addis

  36. Clinical evidence continuous medical education: a randomised educational trial of an open access e-learning program for transferring evidence-based information – ICEKUBE (Italian Clinical Evidence Knowledge Utilization Behaviour Evaluation) – study pro...

    Article • Implementation Science, July 2008, Springer Science + Business Media

    PhD Antonio Addis

  37. Impact of Body Mass Index and Obesity on Clinical Response to Systemic Treatment for Psoriasis

    Article • Dermatology, January 2008, Karger Publishers

    PhD Antonio Addis

  38. Response to the letter by Williams et al.

    Article • Intensive Care Medicine, June 2007, Springer Science + Business Media

    PhD Antonio Addis

  39. Using Clinical Evidence in a National Continuing Medical Education Program in Italy

    Article • PLoS Medicine, May 2007, PLOS

    PhD Antonio Addis

  40. Use of Drotrecogin alfa (activated) in Italian intensive care units: the results of a nationwide survey

    Article • Intensive Care Medicine, February 2007, Springer Science + Business Media

    PhD Antonio Addis

  41. Folic acid: a public-health challenge

    Article • The Lancet, June 2006, Elsevier

    PhD Antonio Addis

  42. European Clinical Trials Directive: the Italian position

    Article • The Lancet, May 2004, Elsevier

    PhD Antonio Addis

  43. Patients' charges in Slovakia

    Article • The Lancet, May 2004, Elsevier

    PhD Antonio Addis

  44. Clinical Evidence: a useful tool for promoting evidence-based practice?

    Article • BMC Health Services Research, December 2003, Springer Science + Business Media

    PhD Antonio Addis

  45. Fetal safety of loratadine use in the first trimester of pregnancy: A multicenter study

    Article • Journal of Allergy and Clinical Immunology, March 2003, Elsevier

    PhD Antonio Addis

  46. Toward estimating the impact of changes in immigrants' insurance eligibility on hospital expenditures for uncompensated care

    Article • BMC Health Services Research, January 2003, Springer Science + Business Media

    PhD Antonio Addis, Liana DesHarnais Bruce, PhD, MSPH

  47. Adverse Effects of Prenatal Methimazole Exposure

    Article • Obstetrical & Gynecological Survey, June 2002, Wolters Kluwer Health

    Dr Francesco Benedicenti, PhD Antonio Addis

  48. New drug treatment for asthma: Clinical versus statistical significance

    Article • The Journal of Pediatrics, April 2002, Elsevier

    PhD Antonio Addis

  49. Relationship between daily dose frequency and adherence to antihypertensive pharmacotherapy: Evidence from a meta-analysis

    Article • Clinical Therapeutics, February 2002, Elsevier

    PhD Antonio Addis

  50. New approaches to analysing prescription data and to transfer pharmacoepidemiological and evidence-based reports to prescribers

    Article • Pharmacoepidemiology and Drug Safety, January 2002, Wiley

    PhD Antonio Addis

  51. Metoclopramide for Nausea and Vomiting of Pregnancy: A Prospective Multicenter International Study

    Article • American Journal of Perinatology, January 2002, Thieme Publishing Group

    PhD Antonio Addis

  52. Pregnancy Outcome Following Gestational Exposure to Venlafaxine: A Multicenter Prospective Controlled Study

    Article • American Journal of Psychiatry, October 2001, American Psychiatric Association

    PhD Antonio Addis

  53. Fetal effects of cocaine: an updated meta-analysis

    Article • Reproductive Toxicology, July 2001, Elsevier

    PhD Antonio Addis

  54. Drug use during pregnancy

    Article • The Lancet, March 2001, Elsevier

    PhD Antonio Addis

  55. Adverse effects of prenatal methimazole exposure

    Article • Teratology, January 2001, Wiley

    Dr Francesco Benedicenti, PhD Antonio Addis

  56. Fetal Effects of Metoclopramide Therapy for Nausea and Vomiting of Pregnancy

    Article • The New England Journal of Medicine and Surgery and the Collateral Branches of Science, August 2000, New England Journal of Medicine (NEJM/MMS)

    PhD Antonio Addis

  57. Prenatal exposure to misoprostol and vascular disruption defects: A case-control study

    Article • American Journal of Medical Genetics, January 2000, Wiley

    PhD Antonio Addis

  58. Risk Classification Systems for Drug Use During Pregnancy

    Article • Drug Safety, January 2000, Springer Science + Business Media

    PhD Antonio Addis

  59. Safety of fluoxetine during the first trimester of pregnancy: a meta-analytical review of epidemiological studies

    Article • Psychological Medicine, January 2000, Cambridge University Press

    PhD Antonio Addis

  60. Pregnancy outcome after gestational exposure to terfenadine: A multicenter, prospective controlled study☆☆☆

    Article • Journal of Allergy and Clinical Immunology, November 1999, Elsevier

    PhD Antonio Addis

  61. Use of nimesulide in children

    Article • The Lancet, September 1999, Elsevier

    PhD Antonio Addis

  62. Meta-analytic review of the clinical effectiveness of oral deferiprone (L 1 )

    Article • European Journal of Clinical Pharmacology, March 1999, Springer Science + Business Media

    PhD Antonio Addis

  63. Benzodiazepine use in pregnancy and major malformations or oral cleft: meta-analysis of cohort and case-control studies

    Article • BMJ, September 1998, BMJ

    PhD Antonio Addis

  64. The safety of omeprazole during pregnancy: A multicenter prospective controlled study

    Article • American Journal of Obstetrics and Gynecology, September 1998, Elsevier

    PhD Antonio Addis

  65. Outcome of children exposed In utero to fluoxetine: A critical review

    Article • Depression and Anxiety, January 1998, Hindawi Publishing Corporation

    PhD Antonio Addis

  66. Article • Pharmacy World & Science, January 1998, Springer Science + Business Media

    PhD Antonio Addis

  67. Quality Assessment of Economic Evaluations Published in PharmacoEconomics

    Article • PharmacoEconomics, December 1997, Springer Science + Business Media

    PhD Antonio Addis

  68. Pharmacoeconomic Analysis of Venlafaxine in the Treatment of Major Depressive Disorder

    Article • PharmacoEconomics, August 1997, Springer Science + Business Media

    PhD Antonio Addis

  69. Article • Digestive Diseases and Sciences, January 1997, Springer Science + Business Media

    PhD Antonio Addis

  70. Vitamin A supplementation during pregnancy in developed countries

    Article • The Lancet, March 1995, Elsevier

    PhD Antonio Addis

  71. Decrease in [3H]hemicholinium binding to high-affinity choline uptake sites in deafferented striatum: restoration by oxiracetam

    Article • Brain Research, October 1990, Elsevier

    PhD Antonio Addis